+ Follow RHEUMATOLOGY AND SKIN DISEASE EDUCATION FOUNDATION Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 617159
[Title] => New agents for gout provide alternatives to allopurinol
[Summary] => The likely approval of febuxostat for the treatment of gout means that there soon will be an alternative for the underserved group of patients with severe disease who cannot tolerate allopurinol.
[DatePublished] => 2010-10-03 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
RHEUMATOLOGY AND SKIN DISEASE EDUCATION FOUNDATION
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 617159
[Title] => New agents for gout provide alternatives to allopurinol
[Summary] => The likely approval of febuxostat for the treatment of gout means that there soon will be an alternative for the underserved group of patients with severe disease who cannot tolerate allopurinol.
[DatePublished] => 2010-10-03 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
abtest
